https://www.prnewswire.com/news-releases/ptc-therapeutics-announces-proposed-public-offering-of-common-stock-300782410.html
/PRNewswire/ -- PTC Therapeutics, Inc. (Nasdaq: PTCT) announced today that it is commencing a public offering of $200 million of shares of its common stock....
ptc therapeuticspublic offeringcommon stockannouncesproposed
https://www.ptcbio-en.se/transparency/
PTC Therapeutics believes that a strong collaboration with patient advocacy groups and physicians is critical to the successful development of novel treatments...
ptc therapeuticstransparencyswedenenglish
https://www.reimaginepku.com/
PTC Therapeutics is here to help you rethink Phenylketonuria (PKU) control. Get access to content and resources for healthcare professionals, patients, and...
ptc therapeuticsreimaginephenylketonuriapku
https://www.fool.com/investing/2017/04/07/why-ptc-therapeutics-dropped-253-in-march.aspx
A handful of negative developments overwhelmed the positive news items released during the month, causing the biotech's stock to crater.
ptc therapeuticsdroppedmarchmotley
https://www.ptcbio.ie/about-ptc/leadership/
The executive leadership team at PTC Therapeutics is a profoundly inspiring group of innovators working toward a brighter future for rare disease treatments.
ptc therapeuticsour leadershipmeetteam
https://www.mql5.com/en/quotes/stocks/ptct
PTCT exchange rate has changed by 3.21% for today. During the day, the instrument was traded at a low of 72.64 and at a high of 74.96
ptc therapeuticsincstockpricesquotes